Impact Asset Management GmbH »

Regeneron Pharmaceuticals shares owned by Impact Asset Management GmbH

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Impact Asset Management GmbH from 13F filings

Historical chart of Impact Asset Management GmbH investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Impact Asset Management GmbH consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Impact Asset Management GmbH

Quarter filed Position value Share count Share price at filing
2025-03-31 $4.3M 6.8k 634.23
2024-12-31 $4.6M 6.5k 712.33
2024-09-30 $6.9M 6.5k 1051.24

More positions owned by Impact Asset Management GmbH

Microsoft Corp Common Stock (MSFT)
Alphabet Common Stock (GOOG)
Mastercard Incorporated Common Stock (MA)
Visa Common Stock (V)
Eli Lilly & Co Common Stock (LLY)
Taiwan Semiconductor Mfg Common Stock (TSM)
Apple Common Stock (AAPL)
Broadcom Common Stock (AVGO)
Mercadolibre Common Stock (MELI)
Intercontinental Exchange In Common Stock (ICE)
Abbvie Common Stock (ABBV)
Lowes Cos Common Stock (LOW)
S&p Global Common Stock (SPGI)
Vertex Pharmaceuticals Common Stock (VRTX)
Pnc Finl Svcs Group Common Stock (PNC)

View all positions for Impact Asset Management GmbH

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Morgan Stanley
Goldman Sachs Group
Nuveen

View all funds holding Regeneron Pharmaceuticals